Semaglutide for Diabetes and Weight Loss Semaglutide is approved for use in managing diabetes and physician-assisted weight loss
Your new dose is being added on top of a slightly higher baseline
Multiple studies have highlighted the glycemic, weight, and cardiac benefits of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP1-RA), treatment in patients with or without type 2 diabetes (T2D)
Restores firmness and youthful elasticity
Check capsules regularly for signs of softening, discoloration, or unusual odors that indicate quality degradation
Speaking to ETPharma, Leena Menghaney, a patient advocate and Lawyer, Public Health, Pharmaceuticals & Access, called the move as a much needed step citing that type-2 diabetes patients also need access to insulin-sparing regimens and these medicines that have been demonstrated to reduce mortality